FindTrial
Sign In

COMPARISON OF VAGINAL CONTRACEPTIVE RING (NUVARING) AND ORAL CONTRACEPTIVE PILL (MALA N) FOR THE TREATMENT OF LOWER ABDOMINAL PAIN PERSISTING FOR SIX OR MORE MONTHS.

COMPARISON OF COMBINED CONTRACEPTIVE VAGINAL RING AND LOW DOSE COMBINED ORAL CONTRACEPTIVE PILL FOR THE TREATMENT OF CHRONIC PELVIC PAIN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/05/003706
Enrollment
66
Registered
2013-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CHRONIC PELVIC PAIN

Interventions

Intervention1: VAGINAL COMBINED CONTRACEPTIVE RING (NUVARING): VAGINAL RING CONTAINS 2.7 mg ETHINYL ESTRADIOL AND 11.7 mg ETONOGESTREL,releases 0.015 mg/day of ethinyl estradiol and 0.120 mg of etonog

Sponsors

GTB HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Sexually active women aged between 18-50 years. • Pelvic pain with duration more than 6 months.

Exclusion criteria

Exclusion criteria: • Post menopausal women •Treatment other than NSAIDs upto 3 months before study entry •Usual contraindications to estrogen and progesterone •Desire to conceive

Design outcomes

Primary

MeasureTime frame
1.Relief of pain in patients i.e., improvement in VAS and VRS in both groups 2.COMPLIANCE- DISCONTINUATION RATETimepoint: 1,2,3 & 4 months—

Secondary

MeasureTime frame
â?¢ Satisfaction rate â?¢ Acceptability rate â?¢ Nausea, headache and breakthrough bleeding â?¢ Weight gain â?¢ Venous thromboembolism â?¢ Serum lipid profile alteration â?¢ Blood pressure changes â?¢ Vaginitis, irritation, discharge per vaginum Timepoint: 1,2,3 & 4 months—

Countries

India

Contacts

Public ContactDR SHALINI RAJARAM

UCMS

rajaram.shalini@gmail.com9868399750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026